戻る Agenda
Session 7: Prescriber and Patient Confidence with Biosimilar Use
Session Chair(s)
Hillel P Cohen, PhD
Biosimilars Expert
Retired, United States
In this session we will review how prescribers and pharmacists are integrating biosimilars into their practices and how biosimilars are being received by patients. We will also review awareness and education efforts that have been implemented, focusing on what has worked and what has not worked as expected.
Learning Objective : At the conclusion of this session, participants should be able to:
- Identify programs implemented to educate healthcare professionals and their patients so that biosimilars are accepted and used
- Understand why some educational programs have been more successful than others
- Gain an appreciation for aspects of biosimilarity that are now well accepted as well as areas of residual concern
Speaker(s)
Best Practices for Biosimilar Integration into Routine Clinical Care
Shubha Bhat, PharmD, MS
Boston Medical Center, Center for Digestive Disorders & Crohn's and Colitis, United States
Ambulatory Care Clinical Pharmacy Specialist - Gastroenterology
Developing a Biosimilar Implementation Plan: Creating a toolkit for success
Ryan Haumschild, PharmD, MBA, MS
Emory Healthcare, United States
Director of Pharmaceutical Sciences
Speaker
Ali McBride, PharmD, MS
The University of Arizona Cancer Center, United States
Clinical Coordinator